Showing results (1461-1470 of 1,566) with videos related to

Sort By:
Pageof 157
Nature Biomedical Engineering|April 28, 2022
A multi-organ chip with matured tissue niches linked by vascular flowKacey Ronaldson-Bouchard, Diogo Teles, Keith Yeager, et al.
ESMO Open|May 20, 2025
HR-SC-an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparibL Beltrame, L Mannarino, A Sergi, et al.
Cancer Discovery|November 14, 2022
OncoLoop: A Network-Based Precision Cancer Medicine FrameworkAlessandro Vasciaveo, Juan Martín Arriaga, Francisca Nunes de Almeida, et al.
Journal of Endourology|February 20, 2025
Early Continence Recovery after Robot-Assisted Radical Prostatectomy: A Multicenter Analysis on the Role of Prostatic ShapeMarco Carilli, Valerio Iacovelli, Marco Sandri, et al.
Plos Computational Biology|May 15, 2013
Improving breast cancer survival analysis through competition-based multidimensional modelingErhan Bilal, Janusz Dutkowski, Justin Guinney, et al.
Clinical Genitourinary Cancer|May 17, 2024
Unmarried Status Effect on Stage at Presentation and Treatment Patterns in Non-Metastatic Upper Tract Urothelial Carcinoma PatientsSimone Morra, Lukas Scheipner, Andrea Baudo, et al.
British Journal of Cancer|July 22, 2022
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22)Lucia Musacchio, Daniela Califano, Michele Bartoletti, et al.
Oncotarget|September 23, 2016
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACCFrancesco Perrone, Gustavo Baldassarre, Stefano Indraccolo, et al.
Leukemia & Lymphoma|April 5, 2018
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana LinfomiFrancesco Zaja, Flavia Salvi, Maura Rossi, et al.
Nature Communications|July 17, 2025
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapyRobert Saddawi-Konefka, Riyam Al Msari, Shiqi Tang, et al.
Pageof 157